Synopsis of recent research by authors named "WeiWei Ouyang"
Weiwei Ouyang's recent research spans multiple domains, including bioremediation of trichloroethene (TCE), cancer therapies focused on lung cancer and solid tumors, and the development of dual inhibitors for enhanced cancer treatment, reflecting a commitment to environmental and health sciences.
Significant findings include the advancement of electrokinetic enhanced bioremediation techniques to improve TCE dechlorination through controlled hydrogen concentration, as well as studies indicating that timing in primary tumor radiotherapy can considerably influence overall survival outcomes in lung cancer patients.
Ouyang's work also explores innovative drug delivery mechanisms, such as cationic liposomes to enhance reovirus efficacy in treating ovarian cancer and the identification of novel small molecule inhibitors targeting the PD-1/PD-L1 pathway for immunotherapy, demonstrating a comprehensive approach to tackling both environmental and oncological challenges.
